Reasons for Admission and Outcome to an Acute Palliative Care Unit in Patients with Advanced Malignancy in a Cancer Hospital by Ghafoor, Irum et al.
Journal Of Cancer & Allied Specialties 1
Original ArticleJ Cancer Allied Spec 2020;6(2):6
Reasons for Admission and Outcome to an Acute Palliative Care Unit in 
Patients with Advanced Malignancy in a Cancer Hospital
Irum Ghafoor1, Abdul Hanan Ali Rasheed1, Aun Raza1, Arif Jamshed2, 
Haroon Hafeez1
1Department of Internal Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, 
Lahore, Pakistan, 2Department of Radiation Oncology, Shaukat Khanum Memorial Cancer Hospital 
and Research Centre, Lahore, Pakistan
Received: 15 March 2020/Accepted: 30 May 2020
Abstract
Introduction: The alleviation of suffering is a primary goal of palliative 
care team for patients with terminal cancer. In some cases, patients 
experience symptoms requiring inpatient care. The purpose of this 
investigation was to assess the clinical presentation and outcomes of 
hospitalisation in patients that were admitted to the acute palliative care 
service. Materials and Methods: This is a retrospective descriptive study 
looking at admissions to an acute palliative care unit in a single centre 
over a 24-month period. Medical records of all patients, admitted in 
palliative care unit from 1 January, 2013, to 31 December, 2014, were 
reviewed for reason of admission and outcome. Results: A total of 
226 patients were identified and included in the present investigation. 
Among these, 55.5% (125) were females. The median age of the cohort 
was 48 (15–86) years. The most common reasons for admission were 
alteration in consciousness (19.5%), respiratory tract infection (18%), 
diarrhoea and/or vomiting (14.2%) and respiratory distress (not related 
to infection) (13.4%). The median duration of hospital stay was 4 (0–
27) days. The majority of the patients were discharged home (65.1%). 
However, a significant portion (33.1%) of the patients did not survive 
the hospitalisation. Following discharge from the hospital, at 4-weeks 
follow-up, the survival rate was 38.7%. This dropped to 21.7% at 8-weeks. 
Conclusion: Patients with advanced disease have a multitude of reasons 
to seek acute inpatient care. The majority of the patients were discharged 
following care. However, the survival rate of patients following discharge 
was low.
Key words: Admission, carcinoma, hospital stay, outcome of admission, 
palliative care
Introduction
The World Health Organisation defines palliative 
care as an approach that improves the quality of 
life of patients and their families who are facing 
problems associated with life-threatening illness.[1,2] 
Palliative care addresses the physical, mental, 
spiritual and social distress caused by serious 
illness to maintain hope, ensure dignity and respect 
the autonomy of patients and families.[2-4]
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Patients seeking care in palliative care units suffer 
from complex problems and need multidisciplinary 
input into their care plan leading to integration of 
all social, spiritual and psycho-physiological needs 
of patients and their families.[2]
However, palliative care interventions while may 
improve quality of life and symptom burden, they 
have no mortality benefit.[5] The need for palliative 
care in cancer patients is higher in low-income 
countries due to late diagnosis, inadequate 
curative care facilities and difficulties in access to 
care.[6] In Pakistan, palliative care is in its infancy 
due to multiple factors including but not limited 
to minimal resource allocation by the government, 
lack of prioritisation of palliative care in the health 
indicators and unrealistic narcotic policies.[7] 
There have been numerous studies conducted 
around the world to understand the reasons 
of admission in acute palliative care unit.[8-10] 
However, to the best of our knowledge, no such 
studies have yet been conducted in Pakistan. 
Therefore, the purpose of this investigation was 
to assess the clinical presentation and outcomes 
of hospitalisation in patients that were admitted to 
the acute palliative care service. 
Materials and Methods
Study design, participants and study setting
A retrospective cross-sectional review of patients 
that were admitted to the acute palliative care 
service of Shaukat Khanum Memorial Cancer 
Hospital and Research Centre, Lahore, Pakistan, 
was conducted for the time period between 1 
January, 2013, and 31 December, 2014. This study 
was approved by the local Institutional Review 
Board (EXMPT-13-12-17-0). 
During the hospital stay, all participants underwent 
comprehensive history and physical examination 
at the time of admission. This included, but was 
not limited to, detailed history of use of antibiotics 
or corticosteroids in past 4 weeks, chemotherapy 
intervention in past 3 months, or use of total parenteral 
nutrition in the month before admission. Similarly, 
patients were assessed for any existing intravascular 
or other invasive devices such as catheters or feeding 
tubes. During admission, all patients underwent 
relevant investigations such as complete blood count, 
renal and liver function tests, and where needed, blood 
and/or wound cultures. Furthermore, patients when 
indicated underwent radiograph and computerised 
tomography imaging to assist with diagnosis and 
management. Patient management was according to 
medical guidelines of National Institute for Health and 
Care Excellence for palliative patients.[11] All patients 
admitted under the acute palliative care service, on 
discharge was followed in the outpatient clinic at 4 
and 8 weeks post discharge.
All patients that were admitted to the acute 
palliative care service were included in the 
investigation. However, if patients were admitted 
for management in any other service, they were 
excluded from the analysis. 
Clinical information
The investigators de-identified the data of all 
participants. Hospital information system was used 
to access medical charts of the patients. Charts were 
reviewed to extract information regarding patient 
demographics, medical and surgical history, 
medication history, number of admissions, length 
of stay, and reason(s) and outcomes for admission 
to the acute palliative care service. Similarly, 
information on the oncological disease, including 
prior and concurrent antineoplastic therapies and 
metastases was recorded.
Statistical analysis
The statistical analysis was performed using 
SPSS version 22.0 software (IBM). Descriptive 
statistics were computed for each variable. Tests 
to determine statistical significance were not 
performed in this investigation.
Results
A total of 226 patients were identified and 
included in the present investigation. Among 
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Table 1: Summary of the study baseline 





Age (years) Median 48 (15–86)












Head and neck 25 (11.1)
Cervix (including uterus 
and ovaries)
20 (8.8)
Brain and spinal cord 19 (8.4)
Lungs (including trachea) 14 (6.2)
Oesophagus and stomach 11 (4.9)
Others (such as pancreas, 
biliary system, kidney, blad-
der, prostate and testes)
49 (21.7%)
Metastasis None 54 (23.9)
Present 172 (76.1)
Table 2: Summary of the presenting complaints 
and/or provisional diagnoses at the time of 
admission
Reason for admission Number (%)
Alteration in consciousness 67 (19.5)
Respiratory tract infection 62 (18.0)
Diarrhoea and/or vomiting 49 (14.2)
Respiratory distress (not associated with 
infection) 
46 (13.4)
Constipation or abdominal issues 26 (7.6)
Pain crisis 20 (5.8)
Renal issues (uremia, obstructive urop-
athy) 
19 (5.5)
Wound care 17 (4.9)
Sepsis 16 (4.7)
Bleeding 12 (3.5)
Other (anaemia, blockage or dislodge-
ment of a drain or stoma)
10 (2.9)
Table 3: Breakdown of the outcome of 
hospitalisation and survival summary at 4-weeks 







Number of discharges 224 (65.1)
Left against medical advice 6 (1.8)
Died during hospitalisation 114 (33.1)




Lost to follow-up 76 (33)




Lost to follow-up 92 (40.7)
these, 55.5% (125) were females. The median 
age of the cohort was 48 (15–86) years. There 
were total of 344 admissions recorded over the 
study period. Nearly 28% of the patients required 
more than one admission to the hospital. The 
most common oncological diseases that required 
admission was breast (19.5%) and colonic cancers 
(19.5%), followed by head and neck carcinomas 
(11.1%). Furthermore, 76.1% (172) of the patients 
had metastatic disease and 37.5% had multiple 
site metastases at the time of admission to the 
acute palliative care service. These results are 
summarised in Table 1. 
The most common reasons for admission were 
alteration in consciousness (19.5%), respiratory 
tract infection (18%), diarrhoea and/or vomiting 
(14.2%) and respiratory distress (not related to 
infection) (13.4%). Summary of the presenting 
complaints and provisional diagnoses at the time 
of admission are given in Table 2. 
The median duration of hospital stay was 4 
(0–27) days. The majority of the patients were 
discharged home (65.1%). However, a significant 
portion (33.1%) of the patients did not survive 
the hospitalisation. Following discharge from the 
hospital, at 4-weeks follow-up, the survival rate was 
38.7%. This dropped to 21.7% at 8-weeks [Table 3].
Discussion
The aim of this investigation was to assess the clinical 
presentation and outcomes of hospitalisation in 
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patients that were admitted to the acute palliative 
care service. Among 226 patients, there were 344 
admissions to the hospital. The most common reasons 
for admission were alteration in consciousness, 
respiratory tract infection, diarrhoea and/or vomiting 
and respiratory distress (not associated with infection). 
Nearly 65% of the patients were discharged following 
the admission to acute palliative care service. Among 
these, the survival rate was approximately 39% at 
4-week follow-up and nearly 22% at 8-week follow-up.
In the present study, the majority of the patients 
that were admitted to the acute palliative care 
service were females and the most common site 
of primary cancer were breast and intestine. This 
is contrary to the findings reported by Hui et al. In 
their investigation, authors reported that males were 
more likely to be admitted to the palliative service. 
Similarly, they reported that the most common sites 
of primary cancer among study participants were 
gastrointestinal and genitourinary carcinomas.[12] A 
possible reason for this disparity is the differences 
in the geographical and the socio-economic factors 
among the two study populations. Furthermore, 
variation in reporting could be attributed to increase 
in awareness campaigns in Pakistan for breast cancer 
compared with other malignancies.[13] Another 
reason for the differences in study population could 
be associated with the mechanism of acceptance of 
patients for care in the hospital where the present 
study was conducted. All new patients are filtered 
through walk-in clinics, which have defined guidelines 
and criteria based on the age of the patient, and type, 
site and stage of the cancer. Therefore, it can cause 
a skewed patient population, which may not reflect 
the true national disease burden.
There were a diverse range of symptoms that 
required admission to the acute palliative 
care service. These consisted of alteration in 
consciousness (19.5%), respiratory tract infection 
(18%), diarrhoea and/or vomiting (14.2%) and 
non-infectious respiratory distress (13.4%). The 
majority of patients that presented with alteration 
in consciousness had an underlying primary brain 
tumour or metastasis and were diagnosed with 
delirium. Underlying causes for admission for 
management of diarrhoea and/or vomiting was 
attributed to the toxicity from use of medications 
(such as opioids or gabapentinoids), gastroparesis, 
brain metastasis and mechanical obstruction 
secondary to extrinsic or intrinsic factors. Similarly, 
patients were admitted with respiratory distress 
secondary to malignant pleural effusion. These 
findings are similar to those reported previously 
in the literature.[14,15]
Pain is a common presentation among patients with 
advanced disease. It has been reported that nearly 
all patients that seek palliative care suffer from pain 
related symptoms.[16] In the present study, 5.8% of 
the patients were admitted with pain crisis. This 
percentage is relatively low in comparison to other 
studies where pain is the cause of presentation in 
more than 10% of patients.[17,18] A possible reason 
for this may be associated with the practice of care 
in the hospital where the present investigation was 
conducted. All patients undergo thorough and 
comprehensive assessment for pain in palliative 
care outpatient clinic. If patients report pain, they 
are then referred to dedicated pain management 
clinics for care.
During the admission to the acute palliative care 
service 33% of the patients died. However, majority 
were discharged. These results are similar to those 
reported earlier.[19] On the contrary, the survival 
was 38.7% at 4-weeks follow-up and 21.7% at 
8-weeks follow-up. These low percentages suggest 
that the palliative patient will have uncertainty of 
prognosis on time to death along with social and 
ethical norms where families come to terms with 
the inevitable and do not always inform the hospital 
if the patient has demised.[20]
There are several limitations in the present study. 
This was a retrospective descriptive analysis. 
By default, the study design did not permit 
assessment of all biopsychosocial characteristics, 
such as severity of symptoms, and performance 
status and psychological well-being of the patient. 
Furthermore, retrospective studies have a high 
potential for recall and observer bias. However, in 
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the present study, data were extracted from the 
electronic hospital information database which 
does not allow tampering or manipulation of the 
data. Similarly, in the present investigation around 
41% of the patients was lost to follow-up after 
discharge, which significantly affected the survival 
rate of the study population.
Patients in palliative care unit usually present with 
their disease at advanced stage, and the symptoms 
experienced by those patients are very dynamic in 
nature. This signifies the diverse role of palliative 
care clinicians who tailor multiple approaches to 
treat diverse ranges of issues faced by patients. The 
cumulative complexity and multi morbid condition 
of patients in palliative care are a great challenge 
to both clinicians and other health-care providers. 
Patients present with wide array of symptoms. 
Palliative care providers need to expand their skills 
and knowledge to address complex intractable 
symptomology rather than focusing only on control 
of few symptoms. More studies are required to 
document the symptomatology and outcomes of 
palliative patients after discharge from hospital.
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